Project Grant K01DA064935
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Trustees of Boston University a $193,751 Project Grant effective May 1, 2026, through April 30, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). This Career Development Award supports a rigorous training and research plan to develop an independent substance use disorder (SUD) services researcher whose work will advance large-scale improvements in SUD care quality. The award funds...
- Federal Grant Award Summary Award Details: Funding Agency: National Institute on Drug Abuse (NIDA) Federal Grant Program: Drug Use and Addiction Research Programs (CFDA 93.279) Award Amount: $193,752 Award Date: April 15, 2025 Project Period: April 15, 2025 – March 31, 2030 Recipient: Boston Medical Center Corporation Products and Services: This K23 Career Development Award supports research and implementation activities focused on promoting positive parenting outcomes for mothers with Opioid...
- Federal Project Grant Award Summary Baystate Medical Center, Inc. received a $187,023 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through August 31, 2030. This mentored research career development award supports a mixed-methods study leveraging Massachusetts' statewide Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program as a natural experiment. The research will...
- Federal Project Grant Award Summary The Medical University of South Carolina received a $182,249 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective July 15, 2025, through June 30, 2029. This award supports the implementation and evaluation of EMPWR (Empowering Pregnant Women Receiving Medications for Opioid Use Disorder), a digitally enhanced intervention designed to improve buprenorphine treatment retention among...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $197,640 Project Grant to Massachusetts General Hospital (MGH) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective March 1, 2026 through February 28, 2030. This four-year research initiative will deliver clinical outcomes research and health economic analysis examining the integration of infectious disease (ID) care into rapid-access substance use disorder (SUD) bridge clinics. The...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Massachusetts Medical School a Project Grant totaling $144,252 under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning September 1, 2025, and concluding August 31, 2030. This mentorship-focused award supports Dr. Carreiro's physician-scientist research program, which applies personalized medicine approaches to substance use disorder (SUD). The grant facilitates training...
- Federal Grant Award Summary New York University School of Medicine received a $208,331 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective August 15, 2025, through July 31, 2030. This K01 career development award supports a multi-level analysis of perinatal toxicology practices in New York State, addressing gaps in substance use screening during pregnancy and postpartum periods when maternal overdose...
- Federal Project Grant Award Summary Boston University Medical Campus received a $109,076 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) with an award date of January 9, 2026 and completion date of July 31, 2029. The award funds basic research to elucidate the role of G Alpha Z (GAZ) protein in behavioral responses to opioids. The research will characterize GAZ expression and downstream signaling pathways in...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston University a $1.478 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning September 30, 2025, and extending through May 31, 2030. The BUP-BOOSTER (Behavioral Optimization for Overcoming Suboptimal Treatment Retention) project develops and evaluates a multicomponent behavioral intervention designed to improve buprenorphine treatment retention at six months...
- Federal Project Grant Award Summary The University of Massachusetts Medical School received a $1.50M Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning September 1, 2025, and concluding May 31, 2030. The grant funds the "Clinical Organization and Legal Agency Alliance Building" (COLAAB) Study, an implementation science initiative designed to increase access to Medications for Opioid Use Disorder...
The National Institute on Drug Abuse awarded Boston University Medical Campus a $193,180 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) effective March 15, 2026, through February 28, 2031. This K01 career development award supports Dr. Auty's training and mentorship to establish herself as an independent investigator examining how Medicaid Managed Care (MMC) networks and policies influence access to care and health outcomes for individuals with opioid use disorder and other substance use disorders. The research specifically targets pregnant women with opioid use disorder (PWOUD), a population at elevated risk for severe maternal morbidity and mortality. The grant funds three primary research objectives: (1) measuring the adequacy of MMC maternity and medications for opioid use disorder provider networks using standard and innovative spatial analytic methods; (2) evaluating geographic variation in network adequacy stratified by PWOUD status; and (3) estimating the impact of state-level network adequacy enforcement policies through financial penalties on service utilization and health outcomes for PWOUD. The project aims to address a critical evidence gap regarding whether current MMC provider networks are sufficient to meet the needs of this vulnerable population and whether network adequacy policies effectively improve care access and maternal health outcomes.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $193.2k | 3/6/26 |